About the Company
PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitor anticancer drugs that block the activity of PD-1 and PDL1 immune checkpoint proteins present on the surface of cells. Immune checkpoint inhibitors are emerging as a front-line treatment for several types of cancer.PD-1 and PD-L1 inhibitors act to inhibit the association of the programmed death-ligand 1 (PD-L1) with its receptor, programmed cell death protein 1 (PD-1). The interaction of these cell surface proteins is involved in the suppression of the immune system and occurs following infection to limit the killing of bystander host cells and prevent autoimmune disease. This immune checkpoint is also active in pregnancy, following tissue allografts, and in different types of cancer.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CKPT News
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds ...
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Checkpoint Therapeutics, Inc. (CKPT) Investors
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Checkpoint Therapeutics, Inc. ("Checkpoint" ...
CKPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Checkpoint Therapeutics, Inc. Investors Can Join the Class Action Lawsuit
Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) Checkpoint had overstated its oversight of, and/or its establishment of ...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Checkpoint Therapeutics, Inc. (CKPT) on Behalf of Investors
today announced that it has commenced an investigation on behalf of Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) investors concerning the Company’s ...
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Checkpoint Therapeutics, Inc. (CKPT) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") (NASDAQ: CKPT) investors concerning the Company's possible ...
Checkpoint Therapeutics, Inc. Stockholder Alert: Robbins LLP Reminds Investors of the CKPT Class Action
Robbins LLP is Investigating the Allegations that Checkpoint Therapeutics, Inc. Overstated the Prospects of its Lead Product Candidate, Cosibelimab ...
Investor Notice: Robbins LLP Informs Investors Of Class Action Filed Against Checkpoint Therapeutics, Inc. (CKPT)
The Allegations: Robbins LLP is Investigating the Allegations that Checkpoint Therapeutics, Inc. Overstated the Prospects of its Lead Product Candidate, Cosibelimab ...
Checkpoint Therapeutics Inc (CKPT)
Gainers: ACMR +48%. ZSAN +49%. AMDA +30%. CHUBA +23%. BZUN +21%. OTCQX:CKPT +20%. CLSD +18%. AMRC +17%. GNCA +15%. INPX +15%.Losers: GLYC -20%. SCYX -18%. MRNS -16% ...
‘Checkpoint Real Estate’: Property success
Henning Marczynski and Beatriz Gonzalez Almas lead the charge at Checkpoint Real Estate, a dynamic duo with roots in Narvik ...
Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer
OSLO, Norway, April 19, 2024 (GLOBE NEWSWIRE) -- (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the ...
Compass Therapeutics begins patient dosing in phase 1 study of CTX-8371 in patients with solid tumours
Compass Therapeutics begins patient dosing in phase 1 study of CTX-8371 in patients with solid tumours: Boston Wednesday, April 17, 2024, 15:00 Hrs [IST] Compass Therapeutics, Inc ...
Shreveport Police to Hold Seatbelt Checkpoint
Buckling up keeps you safe and secure inside of your vehicle and prevents ejection which often results in death.
Loading the latest forecasts...